

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.81733814 |
| 2 | vocalization behavior (GO:0071625) | 5.24973267 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.18256652 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.15805804 |
| 5 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.05392332 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 5.01777226 |
| 7 | * locomotory exploration behavior (GO:0035641) | 5.00041378 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.99334762 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95038076 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.89953689 |
| 11 | glutamate secretion (GO:0014047) | 4.76504030 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.65002231 |
| 13 | glutamate receptor signaling pathway (GO:0007215) | 4.59523154 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.56009378 |
| 15 | protein localization to synapse (GO:0035418) | 4.50903383 |
| 16 | gamma-aminobutyric acid transport (GO:0015812) | 4.48785458 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.33220627 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 4.28552088 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.25226783 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.19837319 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.15854977 |
| 22 | * exploration behavior (GO:0035640) | 4.10445058 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.08894816 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.07585727 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.05152595 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.05116900 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 4.04608314 |
| 28 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.01066436 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.00565366 |
| 30 | proline transport (GO:0015824) | 3.99045242 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.93605908 |
| 32 | long-term memory (GO:0007616) | 3.92394837 |
| 33 | central nervous system myelination (GO:0022010) | 3.91491064 |
| 34 | axon ensheathment in central nervous system (GO:0032291) | 3.91491064 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.86937061 |
| 36 | sodium ion export (GO:0071436) | 3.85590645 |
| 37 | transmission of nerve impulse (GO:0019226) | 3.81611837 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.79304336 |
| 39 | neuron recognition (GO:0008038) | 3.77866381 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.76773877 |
| 41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.71519369 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.70941460 |
| 43 | L-amino acid import (GO:0043092) | 3.70121003 |
| 44 | regulation of synapse structural plasticity (GO:0051823) | 3.66843892 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.62678773 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.62454713 |
| 47 | postsynaptic membrane organization (GO:0001941) | 3.61029951 |
| 48 | neurotransmitter transport (GO:0006836) | 3.57755393 |
| 49 | axonal fasciculation (GO:0007413) | 3.55412624 |
| 50 | mechanosensory behavior (GO:0007638) | 3.53284963 |
| 51 | cell communication by electrical coupling (GO:0010644) | 3.52442278 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.52337853 |
| 53 | regulation of postsynaptic membrane potential (GO:0060078) | 3.47728545 |
| 54 | positive regulation of synapse assembly (GO:0051965) | 3.47465100 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.47256029 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.45215951 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.44563069 |
| 58 | presynaptic membrane assembly (GO:0097105) | 3.43944420 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.42605127 |
| 60 | response to auditory stimulus (GO:0010996) | 3.41639121 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 3.41058978 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39560834 |
| 63 | nucleobase catabolic process (GO:0046113) | 3.36292590 |
| 64 | response to pheromone (GO:0019236) | 3.35634023 |
| 65 | regulation of neurotransmitter levels (GO:0001505) | 3.33335488 |
| 66 | regulation of synaptic plasticity (GO:0048167) | 3.32359470 |
| 67 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31570400 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 3.30678591 |
| 69 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.30670730 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.27531310 |
| 71 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25954834 |
| 72 | response to histamine (GO:0034776) | 3.24757722 |
| 73 | amino acid import (GO:0043090) | 3.23952235 |
| 74 | auditory behavior (GO:0031223) | 3.20891946 |
| 75 | positive regulation of synapse maturation (GO:0090129) | 3.18993484 |
| 76 | neuronal ion channel clustering (GO:0045161) | 3.18959222 |
| 77 | regulation of neurotransmitter secretion (GO:0046928) | 3.16813839 |
| 78 | presynaptic membrane organization (GO:0097090) | 3.16800105 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 3.15847522 |
| 80 | innervation (GO:0060384) | 3.15703779 |
| 81 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.14646008 |
| 82 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.14501317 |
| 83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.14131152 |
| 84 | synapse assembly (GO:0007416) | 3.11957079 |
| 85 | regulation of vesicle fusion (GO:0031338) | 3.11475167 |
| 86 | neuromuscular process controlling posture (GO:0050884) | 3.10362151 |
| 87 | serotonin metabolic process (GO:0042428) | 3.09844450 |
| 88 | glycine transport (GO:0015816) | 3.09093015 |
| 89 | activation of protein kinase A activity (GO:0034199) | 3.06085788 |
| 90 | cellular sodium ion homeostasis (GO:0006883) | 3.05944278 |
| 91 | membrane depolarization during action potential (GO:0086010) | 3.03648103 |
| 92 | membrane depolarization (GO:0051899) | 3.02828066 |
| 93 | membrane hyperpolarization (GO:0060081) | 3.02333966 |
| 94 | behavioral defense response (GO:0002209) | 3.01754276 |
| 95 | behavioral fear response (GO:0001662) | 3.01754276 |
| 96 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.01394385 |
| 97 | learning (GO:0007612) | 3.01064242 |
| 98 | potassium ion import (GO:0010107) | 2.99511477 |
| 99 | cell migration in hindbrain (GO:0021535) | 2.99444705 |
| 100 | establishment of mitochondrion localization (GO:0051654) | 2.99145021 |
| 101 | neuromuscular synaptic transmission (GO:0007274) | 2.97500261 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.96992772 |
| 103 | positive regulation of dendritic spine development (GO:0060999) | 2.96878156 |
| 104 | startle response (GO:0001964) | 2.94801516 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.94756233 |
| 106 | prepulse inhibition (GO:0060134) | 2.93539038 |
| 107 | adult walking behavior (GO:0007628) | 2.92985070 |
| 108 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.91242232 |
| 109 | synapse organization (GO:0050808) | 2.89637066 |
| 110 | regulation of respiratory system process (GO:0044065) | 2.89323815 |
| 111 | neuronal action potential (GO:0019228) | 2.89263507 |
| 112 | potassium ion homeostasis (GO:0055075) | 2.88518927 |
| 113 | regulation of synaptic transmission (GO:0050804) | 2.88078982 |
| 114 | synaptic transmission (GO:0007268) | 2.86787584 |
| 115 | glycosphingolipid biosynthetic process (GO:0006688) | 2.85185365 |
| 116 | primary amino compound metabolic process (GO:1901160) | 2.78364637 |
| 117 | regulation of synapse assembly (GO:0051963) | 2.77889843 |
| 118 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.76999780 |
| 119 | C4-dicarboxylate transport (GO:0015740) | 2.76006836 |
| 120 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.75971221 |
| 121 | regulation of synapse maturation (GO:0090128) | 2.75369089 |
| 122 | adult behavior (GO:0030534) | 2.75013674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.76643812 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75950090 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09589308 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05569086 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04169879 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65317596 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65317596 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58934016 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58251257 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57067305 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54962099 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46594681 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45859047 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45831695 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44295150 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40654837 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.38232609 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18453438 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17979155 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14575451 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.13350448 |
| 22 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.11438053 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05612270 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02759069 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01933708 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00019389 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98399635 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84842613 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76291888 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72666580 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71421223 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70738498 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70483644 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63277318 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60397811 |
| 36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57977097 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53297523 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51032459 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45870086 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45320145 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43495014 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41284869 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.40889191 |
| 44 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37957199 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37834460 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37222284 |
| 47 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35532995 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35509520 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32567822 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32360957 |
| 51 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31900903 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31656557 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31634743 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31245160 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.30613467 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30576702 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29250385 |
| 58 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28625272 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27977671 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27828796 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25251818 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24766792 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.22919747 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16645661 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15605621 |
| 66 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15102886 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14664077 |
| 68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14162408 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13105404 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12640236 |
| 71 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11647399 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10997949 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10820350 |
| 74 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09867382 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08576683 |
| 76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07561919 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07462221 |
| 78 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06809313 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06745075 |
| 80 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05422743 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05200334 |
| 82 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04900129 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03844659 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02372901 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01289242 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01289242 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99922873 |
| 88 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99690958 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99113556 |
| 90 | * FUS_26573619_Chip-Seq_HEK293_Human | 0.98962100 |
| 91 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.98908566 |
| 92 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98890449 |
| 93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98414321 |
| 94 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98403364 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98139161 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97674395 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96975759 |
| 98 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.96722378 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96160880 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95830681 |
| 101 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95235726 |
| 102 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.94831279 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94557265 |
| 104 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94267372 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94267372 |
| 106 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94101037 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93637910 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90761671 |
| 109 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90737076 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90284980 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.89247367 |
| 112 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.88794399 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86641528 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86606556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.19830015 |
| 2 | MP0003880_abnormal_central_pattern | 4.80771574 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.04717868 |
| 4 | MP0004270_analgesia | 3.54662564 |
| 5 | MP0009745_abnormal_behavioral_response | 3.37710848 |
| 6 | MP0009046_muscle_twitch | 3.26244454 |
| 7 | MP0002064_seizures | 3.17461083 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.16417957 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.03477086 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.94373894 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.77967658 |
| 12 | MP0001486_abnormal_startle_reflex | 2.77075504 |
| 13 | MP0002272_abnormal_nervous_system | 2.61257230 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.58769895 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.35570942 |
| 16 | MP0002736_abnormal_nociception_after | 2.34745609 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.24427910 |
| 18 | * MP0001440_abnormal_grooming_behavior | 2.18512148 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.07840497 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.03711289 |
| 21 | MP0004858_abnormal_nervous_system | 2.00408429 |
| 22 | MP0000778_abnormal_nervous_system | 1.99859002 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.97061783 |
| 24 | MP0003329_amyloid_beta_deposits | 1.96414297 |
| 25 | MP0008569_lethality_at_weaning | 1.93640285 |
| 26 | MP0001970_abnormal_pain_threshold | 1.93615118 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.86852660 |
| 28 | MP0002184_abnormal_innervation | 1.84525905 |
| 29 | MP0004885_abnormal_endolymph | 1.84000703 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.83772398 |
| 31 | * MP0002557_abnormal_social/conspecific_i | 1.76085267 |
| 32 | MP0004924_abnormal_behavior | 1.75492640 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.75492640 |
| 34 | MP0002822_catalepsy | 1.68523425 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.64179427 |
| 36 | MP0000955_abnormal_spinal_cord | 1.58377438 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.55014526 |
| 38 | MP0004142_abnormal_muscle_tone | 1.53639192 |
| 39 | MP0001984_abnormal_olfaction | 1.48666317 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.47846459 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.42482330 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.39994324 |
| 43 | MP0001529_abnormal_vocalization | 1.39451903 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.39427835 |
| 45 | MP0003633_abnormal_nervous_system | 1.39020409 |
| 46 | MP0003122_maternal_imprinting | 1.38910661 |
| 47 | MP0003690_abnormal_glial_cell | 1.38493473 |
| 48 | MP0003136_yellow_coat_color | 1.35890165 |
| 49 | MP0001905_abnormal_dopamine_level | 1.34128854 |
| 50 | MP0003879_abnormal_hair_cell | 1.30689527 |
| 51 | MP0003787_abnormal_imprinting | 1.30189464 |
| 52 | MP0003121_genomic_imprinting | 1.26574032 |
| 53 | MP0003631_nervous_system_phenotype | 1.21592326 |
| 54 | MP0004742_abnormal_vestibular_system | 1.16968321 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.15097521 |
| 56 | MP0002152_abnormal_brain_morphology | 1.14677638 |
| 57 | MP0000566_synostosis | 1.13234666 |
| 58 | MP0003634_abnormal_glial_cell | 1.08475634 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.06658569 |
| 60 | MP0002229_neurodegeneration | 1.06421567 |
| 61 | MP0000920_abnormal_myelination | 1.06233974 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.05306601 |
| 63 | MP0001188_hyperpigmentation | 1.04969416 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.04267418 |
| 65 | MP0003632_abnormal_nervous_system | 1.01054905 |
| 66 | MP0001963_abnormal_hearing_physiology | 0.97724041 |
| 67 | MP0004133_heterotaxia | 0.97093649 |
| 68 | MP0000751_myopathy | 0.95670676 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.94936023 |
| 70 | MP0001986_abnormal_taste_sensitivity | 0.93000782 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.91987209 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 0.89875539 |
| 73 | MP0008872_abnormal_physiological_respon | 0.88469866 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.87373974 |
| 75 | MP0001299_abnormal_eye_distance/ | 0.87254442 |
| 76 | MP0002752_abnormal_somatic_nervous | 0.86967273 |
| 77 | MP0000604_amyloidosis | 0.86517985 |
| 78 | MP0001177_atelectasis | 0.84809697 |
| 79 | MP0004215_abnormal_myocardial_fiber | 0.83798266 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.83394960 |
| 81 | MP0003123_paternal_imprinting | 0.81756803 |
| 82 | MP0006292_abnormal_olfactory_placode | 0.80648251 |
| 83 | MP0005409_darkened_coat_color | 0.80281780 |
| 84 | MP0004085_abnormal_heartbeat | 0.80133357 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.78847744 |
| 86 | MP0003119_abnormal_digestive_system | 0.78685259 |
| 87 | MP0008874_decreased_physiological_sensi | 0.76540704 |
| 88 | MP0002090_abnormal_vision | 0.76412647 |
| 89 | MP0002751_abnormal_autonomic_nervous | 0.75503642 |
| 90 | MP0003938_abnormal_ear_development | 0.74621141 |
| 91 | MP0002102_abnormal_ear_morphology | 0.72680742 |
| 92 | MP0005535_abnormal_body_temperature | 0.72572184 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.70190690 |
| 94 | MP0003283_abnormal_digestive_organ | 0.70048447 |
| 95 | MP0004043_abnormal_pH_regulation | 0.68585647 |
| 96 | MP0002938_white_spotting | 0.67854019 |
| 97 | MP0003075_altered_response_to | 0.67727684 |
| 98 | MP0005195_abnormal_posterior_eye | 0.67445861 |
| 99 | MP0005187_abnormal_penis_morphology | 0.66013644 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.65305737 |
| 101 | MP0005171_absent_coat_pigmentation | 0.65047094 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.64814984 |
| 103 | MP0004484_altered_response_of | 0.64643575 |
| 104 | MP0000026_abnormal_inner_ear | 0.64568487 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.64278189 |
| 106 | MP0005499_abnormal_olfactory_system | 0.64278189 |
| 107 | MP0004147_increased_porphyrin_level | 0.62696223 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.62691393 |
| 109 | MP0005253_abnormal_eye_physiology | 0.60518795 |
| 110 | MP0001664_abnormal_digestion | 0.58765044 |
| 111 | MP0003861_abnormal_nervous_system | 0.57936997 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.57405958 |
| 113 | MP0001943_abnormal_respiration | 0.56948928 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.56148530 |
| 115 | MP0010769_abnormal_survival | 0.54663605 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.54597176 |
| 117 | MP0002082_postnatal_lethality | 0.53083837 |
| 118 | MP0010770_preweaning_lethality | 0.53083837 |
| 119 | MP0004233_abnormal_muscle_weight | 0.52334922 |
| 120 | MP0004510_myositis | 0.51736517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.50025817 |
| 2 | Myokymia (HP:0002411) | 6.00554685 |
| 3 | Focal seizures (HP:0007359) | 5.63306846 |
| 4 | Visual hallucinations (HP:0002367) | 4.88263669 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.75349816 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.70964633 |
| 7 | Atonic seizures (HP:0010819) | 4.42734966 |
| 8 | Febrile seizures (HP:0002373) | 4.34435068 |
| 9 | Action tremor (HP:0002345) | 4.17281606 |
| 10 | Absence seizures (HP:0002121) | 4.03243679 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.89585760 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.82160637 |
| 13 | Dialeptic seizures (HP:0011146) | 3.75374961 |
| 14 | Broad-based gait (HP:0002136) | 3.56714350 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.42107179 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.36980474 |
| 17 | Hyperventilation (HP:0002883) | 3.28407173 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.26294657 |
| 19 | Abnormality of binocular vision (HP:0011514) | 3.19361922 |
| 20 | Diplopia (HP:0000651) | 3.19361922 |
| 21 | Dysmetria (HP:0001310) | 3.16712260 |
| 22 | Hemiparesis (HP:0001269) | 3.14892130 |
| 23 | Abnormal eating behavior (HP:0100738) | 3.14071906 |
| 24 | Truncal ataxia (HP:0002078) | 3.09746050 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 3.06776948 |
| 26 | Mutism (HP:0002300) | 3.04320064 |
| 27 | Ankle clonus (HP:0011448) | 3.01013632 |
| 28 | Megalencephaly (HP:0001355) | 3.00045420 |
| 29 | Postural instability (HP:0002172) | 2.95623338 |
| 30 | Depression (HP:0000716) | 2.95440713 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.91858284 |
| 32 | Poor eye contact (HP:0000817) | 2.86681709 |
| 33 | Genetic anticipation (HP:0003743) | 2.86567841 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.81889079 |
| 35 | Excessive salivation (HP:0003781) | 2.80751871 |
| 36 | Drooling (HP:0002307) | 2.80751871 |
| 37 | Anxiety (HP:0000739) | 2.79548479 |
| 38 | Hemiplegia (HP:0002301) | 2.76476428 |
| 39 | Aplasia involving bones of the extremities (HP:0009825) | 2.74878595 |
| 40 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.74878595 |
| 41 | Aplasia of the phalanges of the hand (HP:0009802) | 2.74878595 |
| 42 | Intention tremor (HP:0002080) | 2.67618494 |
| 43 | Abnormal social behavior (HP:0012433) | 2.67611926 |
| 44 | Impaired social interactions (HP:0000735) | 2.67611926 |
| 45 | Scanning speech (HP:0002168) | 2.65405374 |
| 46 | Papilledema (HP:0001085) | 2.60251310 |
| 47 | Progressive inability to walk (HP:0002505) | 2.58953002 |
| 48 | Polyphagia (HP:0002591) | 2.57755047 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 2.52435733 |
| 50 | Spastic gait (HP:0002064) | 2.47476292 |
| 51 | Amblyopia (HP:0000646) | 2.46283578 |
| 52 | Limb dystonia (HP:0002451) | 2.41533292 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.40981610 |
| 54 | Status epilepticus (HP:0002133) | 2.40045730 |
| 55 | Fetal akinesia sequence (HP:0001989) | 2.39199402 |
| 56 | Absent speech (HP:0001344) | 2.38575534 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.36244994 |
| 58 | Bradykinesia (HP:0002067) | 2.35164734 |
| 59 | Pheochromocytoma (HP:0002666) | 2.34144804 |
| 60 | Urinary urgency (HP:0000012) | 2.27506631 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25326683 |
| 62 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.22823934 |
| 63 | Stereotypic behavior (HP:0000733) | 2.18985650 |
| 64 | Medial flaring of the eyebrow (HP:0010747) | 2.17974737 |
| 65 | Termporal pattern (HP:0011008) | 2.17640786 |
| 66 | Insidious onset (HP:0003587) | 2.17640786 |
| 67 | Lower limb muscle weakness (HP:0007340) | 2.15219282 |
| 68 | Sleep apnea (HP:0010535) | 2.14070206 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.13596540 |
| 70 | True hermaphroditism (HP:0010459) | 2.13084627 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.09390962 |
| 72 | Nephronophthisis (HP:0000090) | 2.07530946 |
| 73 | Protruding tongue (HP:0010808) | 2.07152791 |
| 74 | Generalized myoclonic seizures (HP:0002123) | 2.06955928 |
| 75 | Blue irides (HP:0000635) | 2.04935156 |
| 76 | Torticollis (HP:0000473) | 2.04521461 |
| 77 | Agitation (HP:0000713) | 2.04007261 |
| 78 | Abnormality of the lower motor neuron (HP:0002366) | 2.01620062 |
| 79 | Neuroendocrine neoplasm (HP:0100634) | 2.01580124 |
| 80 | Pancreatic fibrosis (HP:0100732) | 1.99810864 |
| 81 | Hepatoblastoma (HP:0002884) | 1.99787366 |
| 82 | Genital tract atresia (HP:0001827) | 1.99456844 |
| 83 | Akinesia (HP:0002304) | 1.98762250 |
| 84 | Vaginal atresia (HP:0000148) | 1.97186363 |
| 85 | Inability to walk (HP:0002540) | 1.96401178 |
| 86 | Aqueductal stenosis (HP:0002410) | 1.96142557 |
| 87 | Impaired vibratory sensation (HP:0002495) | 1.95441213 |
| 88 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94443086 |
| 89 | Oligodactyly (hands) (HP:0001180) | 1.93847022 |
| 90 | Psychosis (HP:0000709) | 1.92815696 |
| 91 | Abnormality of the labia minora (HP:0012880) | 1.92767508 |
| 92 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91766363 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 1.91692120 |
| 94 | Abnormality of salivation (HP:0100755) | 1.91658565 |
| 95 | Gait ataxia (HP:0002066) | 1.90984228 |
| 96 | Spastic tetraplegia (HP:0002510) | 1.90329568 |
| 97 | Focal dystonia (HP:0004373) | 1.90031721 |
| 98 | Molar tooth sign on MRI (HP:0002419) | 1.89948338 |
| 99 | Abnormality of midbrain morphology (HP:0002418) | 1.89948338 |
| 100 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88965831 |
| 101 | Clumsiness (HP:0002312) | 1.88396922 |
| 102 | Peripheral hypomyelination (HP:0007182) | 1.84566349 |
| 103 | Dysmetric saccades (HP:0000641) | 1.83181305 |
| 104 | Pancreatic cysts (HP:0001737) | 1.81660793 |
| 105 | Hypoplasia of the corpus callosum (HP:0002079) | 1.81169145 |
| 106 | Incomplete penetrance (HP:0003829) | 1.80420413 |
| 107 | Rigidity (HP:0002063) | 1.80398489 |
| 108 | Ventricular fibrillation (HP:0001663) | 1.78279218 |
| 109 | Gait imbalance (HP:0002141) | 1.76780948 |
| 110 | Abnormality of saccadic eye movements (HP:0000570) | 1.76338321 |
| 111 | Optic nerve hypoplasia (HP:0000609) | 1.76112172 |
| 112 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.75580356 |
| 113 | Narrow nasal bridge (HP:0000446) | 1.74571753 |
| 114 | Cutaneous finger syndactyly (HP:0010554) | 1.74440522 |
| 115 | Retinal dysplasia (HP:0007973) | 1.73712128 |
| 116 | Specific learning disability (HP:0001328) | 1.72513807 |
| 117 | Esotropia (HP:0000565) | 1.72380101 |
| 118 | Lissencephaly (HP:0001339) | 1.69839492 |
| 119 | Inappropriate behavior (HP:0000719) | 1.69215912 |
| 120 | Poor coordination (HP:0002370) | 1.68899157 |
| 121 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.68707721 |
| 122 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.68707721 |
| 123 | Insomnia (HP:0100785) | 1.68130131 |
| 124 | Postural tremor (HP:0002174) | 1.67126654 |
| 125 | Abnormal EKG (HP:0003115) | 1.66218099 |
| 126 | Abnormal drinking behavior (HP:0030082) | 1.66202547 |
| 127 | Polydipsia (HP:0001959) | 1.66202547 |
| 128 | Abnormality of the renal medulla (HP:0100957) | 1.65107409 |
| 129 | Failure to thrive in infancy (HP:0001531) | 1.64063184 |
| 130 | Vitreoretinal degeneration (HP:0000655) | 1.62772097 |
| 131 | Cystic liver disease (HP:0006706) | 1.61783204 |
| 132 | Split foot (HP:0001839) | 1.60549796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.65169047 |
| 2 | EPHA4 | 3.96439415 |
| 3 | MARK1 | 3.57907153 |
| 4 | MAP3K9 | 3.35967809 |
| 5 | MAP3K4 | 2.96834135 |
| 6 | TNIK | 2.93412247 |
| 7 | NTRK2 | 2.64478272 |
| 8 | MINK1 | 2.62781206 |
| 9 | MAP2K7 | 2.53015793 |
| 10 | FRK | 2.23252180 |
| 11 | CASK | 2.20102341 |
| 12 | PAK6 | 2.00816294 |
| 13 | NTRK1 | 1.82424748 |
| 14 | MAP2K4 | 1.81106064 |
| 15 | MAPK13 | 1.80251450 |
| 16 | MAP3K12 | 1.75592613 |
| 17 | PHKG2 | 1.63851160 |
| 18 | PHKG1 | 1.63851160 |
| 19 | DAPK2 | 1.63699862 |
| 20 | KSR2 | 1.59327787 |
| 21 | PNCK | 1.59325513 |
| 22 | RIPK4 | 1.58938734 |
| 23 | PRKD3 | 1.52735301 |
| 24 | CDK5 | 1.50004443 |
| 25 | CAMKK1 | 1.47530634 |
| 26 | PRPF4B | 1.45414482 |
| 27 | DYRK2 | 1.40668393 |
| 28 | KSR1 | 1.39708524 |
| 29 | SIK2 | 1.35082339 |
| 30 | PRKCG | 1.33898644 |
| 31 | PLK2 | 1.32642831 |
| 32 | FES | 1.28203928 |
| 33 | INSRR | 1.26488528 |
| 34 | GRK5 | 1.24611796 |
| 35 | STK38 | 1.21576325 |
| 36 | TYRO3 | 1.16614326 |
| 37 | LMTK2 | 1.11758925 |
| 38 | CAMK2A | 1.11563828 |
| 39 | CDK19 | 1.09822272 |
| 40 | DAPK1 | 1.05053767 |
| 41 | UHMK1 | 1.05019431 |
| 42 | SGK223 | 1.00085303 |
| 43 | SGK494 | 1.00085303 |
| 44 | MAP3K13 | 0.99790232 |
| 45 | BMPR1B | 0.99281542 |
| 46 | CAMKK2 | 0.98668320 |
| 47 | LATS2 | 0.96508842 |
| 48 | SGK2 | 0.90173816 |
| 49 | MAP3K2 | 0.89622156 |
| 50 | CAMK2B | 0.89129969 |
| 51 | OXSR1 | 0.88905244 |
| 52 | CAMK1 | 0.88040465 |
| 53 | ARAF | 0.86700928 |
| 54 | CDK18 | 0.85399398 |
| 55 | CDK15 | 0.84680614 |
| 56 | PAK3 | 0.83152116 |
| 57 | CDK14 | 0.82921511 |
| 58 | CSNK1G2 | 0.82400828 |
| 59 | ADRBK2 | 0.79110464 |
| 60 | STK11 | 0.78852972 |
| 61 | CAMK1G | 0.77062931 |
| 62 | PRKCH | 0.76919266 |
| 63 | RET | 0.75129783 |
| 64 | SGK1 | 0.74953021 |
| 65 | DYRK1A | 0.74301894 |
| 66 | WNK1 | 0.73917548 |
| 67 | CDK11A | 0.73079763 |
| 68 | SGK3 | 0.71623253 |
| 69 | CSNK1G3 | 0.71359135 |
| 70 | MARK2 | 0.69232920 |
| 71 | NEK6 | 0.68887630 |
| 72 | FGR | 0.68443445 |
| 73 | CSNK1A1L | 0.67801044 |
| 74 | MAP4K2 | 0.66317148 |
| 75 | CSNK1G1 | 0.63963222 |
| 76 | PINK1 | 0.63668779 |
| 77 | PRKCE | 0.61159729 |
| 78 | CAMK4 | 0.59575537 |
| 79 | BMPR2 | 0.58584409 |
| 80 | CAMK2D | 0.58036990 |
| 81 | MAPK15 | 0.57579897 |
| 82 | PKN1 | 0.56691446 |
| 83 | PTK2B | 0.56553771 |
| 84 | MUSK | 0.56521549 |
| 85 | AKT3 | 0.56405835 |
| 86 | ALK | 0.56347713 |
| 87 | CAMK2G | 0.55441278 |
| 88 | MKNK2 | 0.55347241 |
| 89 | TNK2 | 0.54897341 |
| 90 | STK39 | 0.54563563 |
| 91 | RAF1 | 0.52866545 |
| 92 | TAOK1 | 0.52309684 |
| 93 | FYN | 0.51850118 |
| 94 | PRKCZ | 0.51454910 |
| 95 | EPHA3 | 0.51258632 |
| 96 | RPS6KA3 | 0.50770609 |
| 97 | ERBB2 | 0.50523822 |
| 98 | PDK1 | 0.50041431 |
| 99 | CDC42BPA | 0.49706803 |
| 100 | PDPK1 | 0.48666356 |
| 101 | GRK1 | 0.48263425 |
| 102 | PRKACA | 0.47642960 |
| 103 | WNK3 | 0.47594315 |
| 104 | MAPK12 | 0.47262282 |
| 105 | WNK4 | 0.46317863 |
| 106 | ROCK2 | 0.46061770 |
| 107 | MAPK10 | 0.45744312 |
| 108 | CSNK1D | 0.44840205 |
| 109 | NME1 | 0.43759135 |
| 110 | FGFR2 | 0.42149720 |
| 111 | MAP3K6 | 0.41148356 |
| 112 | DMPK | 0.40799702 |
| 113 | SIK3 | 0.40426173 |
| 114 | ERBB3 | 0.38813157 |
| 115 | CSNK1E | 0.38637244 |
| 116 | EPHB2 | 0.38084538 |
| 117 | FER | 0.37964330 |
| 118 | CSNK1A1 | 0.37594419 |
| 119 | BCR | 0.37508701 |
| 120 | ADRBK1 | 0.37127753 |
| 121 | PRKG1 | 0.36674101 |
| 122 | MAP3K7 | 0.33903867 |
| 123 | PRKCB | 0.33784768 |
| 124 | MAPKAPK5 | 0.33526494 |
| 125 | ROCK1 | 0.33468878 |
| 126 | PRKACB | 0.32944021 |
| 127 | PRKCA | 0.32791984 |
| 128 | CDK3 | 0.32453338 |
| 129 | GSK3B | 0.30743832 |
| 130 | LIMK1 | 0.30377632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.09234301 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94077753 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.81092211 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.76198403 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73699981 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.65726793 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.61982913 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.47646896 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.39309815 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.32496244 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.25004461 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11441622 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05136842 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.94447062 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90493618 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.84778185 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83336482 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.77957305 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75408647 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68903973 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.65213557 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.62678560 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61588505 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56441457 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53157386 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52555752 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42577920 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34988459 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.32852348 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29622498 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.28997815 |
| 32 | Axon guidance_Homo sapiens_hsa04360 | 1.28942236 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.28093356 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26236820 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23195736 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22282435 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15819467 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13345459 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08849951 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07682427 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01629750 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.00327483 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.00189307 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99871472 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98175539 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97164075 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96817542 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95905823 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90142072 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.89410505 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88369180 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87270723 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86797560 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79651015 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79439044 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78681168 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73826169 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73625204 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72181798 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72134691 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72074700 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69259490 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69166537 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67652786 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66824610 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66690080 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65953455 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64965591 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64942665 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63693442 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61751271 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.61331268 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60445064 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59970235 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58736287 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57925658 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55134851 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52392216 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51661701 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51092619 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50976845 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50176966 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48095245 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47691051 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47273993 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47035286 |
| 87 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45770824 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43204013 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43045248 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41958330 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.41805057 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41803192 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41405285 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41006611 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.39891720 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.39811173 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39740940 |
| 98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39624082 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39422552 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.38005406 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.37899301 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37594982 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37165306 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34993547 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34492348 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33955571 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33418991 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32533420 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.32253435 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32158552 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31607610 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31041881 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30601046 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29460991 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26600518 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26228078 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26085319 |
| 118 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26011440 |

